Ameya J. Limaye

Ameya J. Limaye

Auto-generated profile, based on publicly available information

Ameya J. Limaye

Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in Science Signaling
Verified
Journal Article
Closed access
TBTimothy R. Baffi
Timothy R. Baffi
GLGema Lordén
Gema Lordén
JWJacob M. Wozniak
Jacob M. Wozniak
AFAndreas Feichtner
Andreas Feichtner
WYWayland Yeung
Wayland Yeung
ANAlexandra C. Newton
Alexandra C. Newton
Phosphorylation of an evolutionarily conserved motif by mTORC2 enables the maturation of AGC kinases.

19 July 2021 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
ALAmeya J. Limaye
Ameya J. Limaye
GBGeorge N. Bendzunas
George N. Bendzunas
EKEileen J. Kennedy
Eileen J. Kennedy
Protein Kinase C (PKC) is a member of the AGC subfamily of kinases and regulates a wide array of signaling pathways and physiological processes. Protein–protein interactions involving PKC and its scaffolding partners dictate the spatiotemporal dynamics of PKC activity, including its access to activating second messenger molecules and potential substrates. While the A Kinase Anchoring Protein (AKAP) family of scaffold proteins universally bind PKA, several were also found to scaffold PKC, thereby serving to tune its catalytic output. Targeting these scaffolding interactions can further shed light on the effect of subcellular compartmentalization on PKC signaling. Here we report the development of two hydrocarbon stapled peptides, CSTAD5 and CSTAD6, that are cell permeable and bind PKC to disrupt PKC–gravin complex formation in cells. Both constrained peptides downregulate PMA-induced cytoskeletal remodeling that is mediated by the PKC–gravin complex as measured by cell rounding. Further, these peptides downregulate PKC substrate phosphorylation and cell motility. To the best of our knowledge, no PKC-selective AKAP disruptors have previously been reported and thus CSTAD5 and CSTAD6 are novel disruptors of PKC scaffolding by AKAPs and may serve as powerful tools for dissecting AKAP-localized PKC signaling.

8 March 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ALAmeya J. Limaye
Ameya J. Limaye
GBGeorge N. Bendzunas
George N. Bendzunas
MWMatthew K. Whittaker
Matthew K. Whittaker
TLTimothy J. LeClair
Timothy J. LeClair
LHLeah G. Helton
Leah G. Helton
EKEileen J. Kennedy
Eileen J. Kennedy

15 July 2020
Verified
Book Chapter
Closed access
PDF file
LHLeah G. Helton
Leah G. Helton
ALAmeya J. Limaye
Ameya J. Limaye
GBGeorge N. Bendzunas
George N. Bendzunas
EKEileen J. Kennedy
Eileen J. Kennedy

28 July 2025 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MWMatthew K. Whittaker
Matthew K. Whittaker
TDTaylor C. Dill
Taylor C. Dill
ALAmeya J. Limaye
Ameya J. Limaye
NTNicholas J. Tsavaris
Nicholas J. Tsavaris
NTNicholas W. Tawadrous
Nicholas W. Tawadrous
EKEileen J. Kennedy
Eileen J. Kennedy